Profilo
Heather Savelle formerly worked at Targacept, Inc., as Senior Director-Investor & Public Relations from 2012 to 2013, Argot Partners LLC, as Senior Vice President & Managing Director from 2016 to 2021, Dynogen Pharmaceuticals, Inc., as Senior Manager-Corporate Communications from 2004 to 2008, Macdougall Biomedical Communications, Inc., as Senior Vice President from 2013 to 2016, and TScan Therapeutics, Inc., as Vice President-Investor Relations from 2021 to 2025.
Ms. Savelle received her undergraduate degree from the University of California, Santa Barbara.
Precedenti posizioni note di Heather Savelle
| Società | Posizione | Fine |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/11/2025 |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy | Corporate Officer/Principal | 01/09/2021 |
Macdougall Biomedical Communications, Inc.
Macdougall Biomedical Communications, Inc. Marine ShippingTransportation Macdougall Biomedical Communications, Inc. is a private company based in Wellesley, MA. | Corporate Officer/Principal | 01/08/2016 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Public Communications Contact | 01/12/2013 |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Public Communications Contact | 01/07/2008 |
Formazione di Heather Savelle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a strategic communications consultancy | Commercial Services |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Macdougall Biomedical Communications, Inc.
Macdougall Biomedical Communications, Inc. Marine ShippingTransportation Macdougall Biomedical Communications, Inc. is a private company based in Wellesley, MA. | Transportation |
















